A first patient has recently been treated at the LUMC with a new immunotherapy for type 1 diabetes (T1D). This marks an important new phase in the approach to this disease. In type 1 diabetes (T1D), the body’s immune system…
-
-
LEIDEN, Netherlands–(BUSINESS WIRE)– Dutch biotech Leyden Laboratories B.V. (the “Company” or “Leyden Labs”) today announced a €40 million investment from the European Innovation Council (EIC) Fund, Invest-NL, Gates Foundation, ClavystBio, and others. The financing brings together a strong group of…
-
LUMC is opening a dedicated outpatient clinic for female employees who are experiencing women-specific health problems. Too often, women with symptoms such as menstrual pain or menopausal complaints are not taken seriously and do not receive the right support. LUMC…
-
Ovaries age faster than the rest of the body. Once women reach their mid-thirties, their supply of eggs begins to decline sharply and menopause comes closer. This natural process affects fertility and increases the risk of health problems such as…
-
On Monday 15 June, we welcomed an American delegation from Kaiser Permanente, Cedars-Sinai and MD Anderson. The visit was organised by Task Force Health Care as part of Health Tech Europe 2026. These three major players in American healthcare came…
-
Ekaterina Zaharieva, EU Commissioner for Start-ups, Research and Innovation, paid a two-day working visit to the Netherlands this week. During the visit, the focus was on the important role of research and innovation in strengthening Europe’s competitiveness. On the first…
-
If approved, Joenja will be the first approved treatment in the U.S. for children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency disorder. The resubmission of the supplemental New Drug Application (sNDA) seeks approval for dosages…
-
An independent review committee has unanimously selected three projects to receive a grant from the Prof. Andrea Evers Fund for Health, Behaviour and Society. The fund, which was launched earlier this year, supports innovative inter- and transdisciplinary research in health…
-
The Dutch technology industry is once again demonstrating the power of innovation: developing solutions that contribute to the future of Europe and the world. With its groundbreaking battery technology, LeydenJar has won the Peter Wennink Tech Award 2026. Through the…
-
Leiden, the Netherlands, May 26th 2026 – VitroScan, a biotechnology company pioneering predictive ex vivo tumor testing, today announced the start of a joint project with scientists from the Radboudumc to advance the development of novel cell therapies for the treatment of ovarian cancer. Ovarian cancer…
-
LUMC and NecstGen are strengthening their development and production facilities for cell and gene therapy by bringing everything together under one roof within LUMC. The strengths of both organizations will be combined, preserving the best of both and allowing them…
-
On the evening of 6 May, a patient with a hantavirus infection was admitted to LUMC. Admission and care have proceeded as planned. Hantavirus confirmed It has been confirmed that the admitted patient has hantavirus. The patient has been informed…